GeoVax Labs (GOVX) Revenue (2010 - 2025)
GeoVax Labs (GOVX) posted quarterly Revenue of $852282.0 for Q2 2025, up 183.45% year-over-year from $300677.0 in Q2 2024, and down 47.93% quarter-over-quarter from $1.6 million in Q1 2025.
GeoVax Labs (GOVX) Revenue (2010 - 2025) Analysis & Trends
GeoVax Labs (GOVX) has reported Revenue for 15 consecutive years, with $852282.0 the latest figure, recorded in Q2 2025.
- In Q2 2025, Revenue rose 183.45% year-over-year to $852282.0; the TTM figure through Jun 2026 stood at $852282.0 (down 86.13% YoY), while the FY2025 annual figure was $2.5 million, down 37.06% from the prior year.
- Revenue slipped to $852282.0 in Q2 2025 per GOVX's latest filing, from $1.6 million in the prior quarter.
- Across five years, Revenue topped out at $2.8 million in Q3 2024 and bottomed at $30414.0 in Q3 2021.
- Historically, Revenue has averaged $691074.8 across 4 years, with a median of $232819.5 in 2021.
- Annual changes were most pronounced in 2021 — Revenue sank 92.68% — and 2025, when it jumped 183.45%.
- GeoVax Labs' Revenue stood at $164962.0 in 2021, then plunged by 50.58% to $81526.0 in 2022, then soared by 960.29% to $864415.0 in 2024, then declined by 1.4% to $852282.0 in 2025.
- Business Quant data shows GOVX's Revenue at $852282.0 in Q2 2025, $1.6 million in Q1 2025, and $864415.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 674.14 Mn |
| 10 | GeoVax Labs | 2.92 Mn | -221,689.59 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 852,282.00 |
| Mar 31, 2025 | 1.64 Mn |
| Dec 31, 2024 | 864,415.00 |
| Sep 30, 2024 | 2.79 Mn |
| Jun 30, 2024 | 300,677.00 |
| Mar 31, 2022 | 81,526.00 |
| Dec 31, 2021 | 164,962.00 |
| Sep 30, 2021 | 30,414.00 |
| Jun 30, 2021 | 79,708.00 |
| Mar 31, 2021 | 110,417.00 |
| Dec 31, 2020 | 251,621.00 |
| Sep 30, 2020 | 415,458.00 |
| Jun 30, 2020 | 440,602.00 |
| Mar 31, 2020 | 715,977.00 |
| Dec 31, 2019 | 268,514.00 |
| Sep 30, 2019 | 333,209.00 |
| Jun 30, 2019 | 209,941.00 |
| Mar 31, 2019 | 364,232.00 |
| Dec 31, 2018 | 299,295.00 |
| Sep 30, 2018 | 349,344.00 |